Institute of Sports Medicine Copenhagen
Copenhagen, 2400, Denmark
NCT Number: NCT02587156
12 elderly (65-70 years of age) male subjects will be included and complete a double blinded cross-over study. They will be habituated for 21 days to either low or high protein intake (below 0.8 g/kg or above 1.5 g/kg, respectively). Following a 45 day washout period they will switch to the alternate group. At the end of each habituation period, the investigators will measure the appearance of labelled amino acids from milk proteins.
Looking for future studies?
Notify Me65 year–70 year
Male
Interventional
Not applicable
Copenhagen, 2400, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
Inclusion criteria
Participants are habituated to a high level of dietary protein intake for 21 days.
Participants are habituated to a low level of dietary protein intake for 21 days.
To investigate impact of habituated protein level
Time frame: Baseline to 240 min postprandial
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:
After intake of milk proteins at time 0 (zero) the quantity of intrinsic labels D5-phe from whey and 15N-phe from casein will be measured in liver-synthesized blood protein at 240 min.
Time frame: Baseline to 240 min postprandial
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:
After intake of milk proteins at time 0 (zero) the quantity of intrinsic labels D5-phe from whey and 15N-phe from casein will be measured in myofibrillar protein at 240 min.
Time frame: Baseline to 240 min postprandial
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:
From arterial and femoral venous blood samples obtained at baseline, 30, 60, 90, 120, 150, 180, 240 min phenylalanine tracer enrichments and concentrations as well as plasma flow will be measured.
Time frame: Baseline to 240 min postprandial
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:
From hepatic venous blood samples obtained at baseline, 30, 60, 90, 120, 150, 180, 240 min phenylalanine tracer enrichments and concentrations as well as plasma flow will be measured. Knowing the amount of ingested protein and labeled phenylalanine we can calculate the first pass splanchnic amino acid extraction.
Time frame: Baseline to 240 min postprandial
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:
From blood samples obtained at baseline, 30, 60, 90, 120, 150, 180, 240 min phenylalanine tracer enrichments will be measured.
Time frame: Baseline to 240 min postprandial
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:
From muscle biopsies obtained at baseline, 60 and 240 min the abundance of phenylalanine tracer bound in the myofibrillar proteins will be measured and the fractional synthesis rate will be measured within the first from baseline to 60 min and 240 min as well as from 60-240 min postprandial.
Time frame: Baseline, 60 min and 240 min postprandial
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:
From baseline to 60 and 240 min after intake of the standardized meal after 21 days of habituation to either a high or a low dietary protein intake expression of signalling proteins related to protein turnover in the muscle will be measured by use of western blotting.
Time frame: Baseline to 240 min postprandial
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:
From blood samples obtained at baseline, 30, 60, 90, 120, 150, 180, 240 min urea tracer enrichments and concentrations will be measured. With this, and flow measurements, we can determine the rate of urea production.
Time frame: 21 days post intervention, 240 min postprandial and 24 hours post the day 21 trial day
Related to the adaptation to the 21 day habituation period to either high or low protein in the diet as well as the response to the standardized trial meal:
Nitrogen and creatinine content is measured in urine is collected for the last 24 h of the 21 day habituation period, as well as during the 240 min trial day and the remaining 20 hours of the trial day.
Time frame: Change from pre-intervention to 21 days and 22 days (21 intervention days habituation and the standardized trial meal on day 21)
Related to the adaptation to the 21 day habituation period to either high or low protein in the diet as well as the response to the standardized trial meal:
The microbiota compositions, will be measured in fecal samples collected before the 21 day habituation period, after the 21 day habituation periode, as well as after the 240 min trial day
Time frame: After 21 days of habituation to either a high or a low dietary protein intake.
Related to the adaptation to the 21 day habituation period to either high or low protein in the diet:
Biopsies taken following the two 21 day habituation period will, by use of western blotting, be analysed for expression of signalling proteins involved in muscle protein turnover.
Bispebjerg Hospital
Other
Fate of Nutrient-Derived Amino Acids: Influence of Habituated Levels of Daily Dietary Protein Intake on Protein Utilization
Acronym: FONDAA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07436936
Dietary Protein, Healthy Aging
Reus, Tarragona, Spain
View Trial DetailsNCT05574205
Atrophy, Dietary Protein
Edgbaston, West Midlands, United Kingdom
View Trial DetailsNCT04887883
Amino Acids, Behavior
Toronto, Ontario, Canada
View Trial DetailsNCT03013764
Behavior, Dietary Protein
Columbia, Missouri, United States
View Trial Details